Authors : Dr. Sabita Aryal; Dr. Liu Ye Qiang

Volume/Issue : Volume 9 - 2024, Issue 4 - April

Google Scholar : https://tinyurl.com/5392enfs

Scribd : https://tinyurl.com/jfmmz4my

DOI : https://doi.org/10.38124/ijisrt/IJISRT24APR2251

Abstract : Extramammary Paget’s disease (EMPD) is an erratic malignant skin disorder primarily affecting skin areas abundant with skin appendages like hair follicles. The vulva is most involved site, followed by genital areas, penoscrotal regions and axillary skin. EMPD presents as erythematous skin lesions resembling eczema, typically progressing slowly, either primary or secondary manifestations. Primary EMPD originates as an intraepithelial neoplasm of the epidermis, often leading to local lymph node metastases and distant metastases. A systematic literature search using targeted keywords across multiple databases was conducted. Studies focusing on EMPD, adnexal involvement, depth, recurrence, and prognosis were included by keeping in view the objective which is to determine the significance of adnexal involvement and depth concerning recurrence and prognosis in the primary EMPD. Adnexal involvement, especially in hair follicles and eccrine ducts, is prevalent in primary EMPD. However, its correlation with tumor progression or recurrence rates remains inconclusive. Surgical excision, including Mohs micrographic surgery, is the primary therapeutic approach, with topical agents and systemic treatments used in advanced cases. Future studies regarding understanding adnexal involvement's depth and significance are essential in designing effective targeted therapeutic approaches in EMPD.

Keywords : Disease of the Cutaneous Annexes, Primary EMPD, Extramammary Paget’s Disease, Skin Neoplasm, Prognosis, Skin Adnexa, Adnexal Involvement.

References :

1. Shaco-Levy, R., et al., Paget disease of the vulva: a study of 56 cases. Eur J Obstet Gynecol Reprod Biol, 2010. 149(1): p. 86-91.
2. Crocker, H.R., Paget's disease affecting the scrotum and penis. Trans Pathol Soc Lond, 1889. 40: p. 187-191.
3. Moretto, P., et al., Management of Penoscrotal Extramammary Paget Disease: Case Series and Review of the Literature. Current Oncology, 2013. 20(4): p. 311-320.
4. Scarbrough, C.A., A. Vrable, and D.R. Carr, Definition, association with malignancy, biologic behavior, and treatment of ectopic extramammary Paget’s disease: A review of the literature. The Journal of clinical and aesthetic dermatology, 2019. 12(8): p. 40.
5. Ohara, K., et al., A proposal for a TNM staging system for extramammary Paget disease: retrospective analysis of 301 patients with invasive primary tumors. Journal of dermatological science, 2016. 83(3): p. 234-239.
6. Abbott, J.J. and I. Ahmed, Adenocarcinoma of mammary-like glands of the vulva: report of a case and review of the literature. The American journal of dermatopathology, 2006. 28(2): p. 127-133.
7. Liegl, B., L.-C. Horn, and F. Moinfar, Androgen receptors are frequently expressed in mammary and extramammary Paget's disease. Modern pathology, 2005. 18(10): p. 1283-1288.
8. Obaidat, N.A., K.O. Alsaad, and D. Ghazarian, Skin adnexal neoplasms—part 2: an approach to tumours of cutaneous sweat glands. Journal of Clinical Pathology, 2007. 60(2): p. 145-159.
9. Yin, S., et al., Prevalence of extramammary Paget's disease in urban China: a population-based study. Orphanet J Rare Dis, 2021. 16(1): p. 1-7.
10. Ghazawi, F.M., et al., Demographic and clinical characteristics of extramammary Paget's disease patients in Japan from 2000 to 2019. Journal of the European Academy of Dermatology and Venereology, 2021. 35(2): p. e133-e135.
11. Zhang, Z., et al., Cutaneous metastases from triple primary extramammary Paget's disease. Journal der Deutschen Dermatologischen Gesellschaft= Journal of the German Society of Dermatology: JDDG, 2020. 18(10): p. 1169-1172.
12. Iwamoto, K., et al., Depigmented extramammary Paget's disease without histological dermal invasion identified by multiple inguinal and pelvic lymph node metastases. European Journal of Dermatology, 2018. 28(3): p. 387-388.
13. St Claire, K., et al., Extramammary paget disease. Dermatology online journal, 2019. 25(4).
14. Payapvipapong, K., A. Nakakes, and M. Tanaka, Lava lake structure and cloud-like structureless area: new clues for diagnosing extramammary Paget disease. Journal of the European Academy of Dermatology and Venereology, 2017. 31(10): p. e459-e461.
15. Mun, J.H., et al., Clinical and dermoscopic characteristics of extramammary Paget disease: a study of 35 cases. British Journal of Dermatology, 2016. 174(5): p. 1104-1107.
16. Regauer, S., Extramammary Paget's disease—a proliferation of adnexal origin? Histopathology, 2006. 48(6): p. 723-729.
17. Blanpain, C., et al., Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell, 2004. 118(5): p. 635-648.
18. Sieber‐Blum, M. and M. Grim, The adult hair follicle: cradle for pluripotent neural crest stem cells. Birth Defects Research Part C: Embryo Today: Reviews, 2004. 72(2): p. 162-172.
19. Tanaka, R., et al., Concordance of the HER2 protein and gene status between primary and corresponding lymph node metastatic sites of extramammary Paget disease. Clinical & experimental metastasis, 2016. 33: p. 687-697.
20. Shiomi, T., et al., Extramammary Paget’s disease: evaluation of the adnexal status of 53 cases. Polish Journal of Pathology, 2015. 66(2): p. 121-126.
21. Preti, M., et al., Vulvar Paget's disease and stromal invasion: clinico-pathological features and survival outcomes. Surgical Oncology, 2021. 38: p. 101581.
22. van der Linden, M., et al., Vulvar Paget disease: a national retrospective cohort study. Journal of the American Academy of Dermatology, 2019. 81(4): p. 956-962.
23. Hatta, N., et al., Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol, 2008. 158(2): p. 313-318.
24. Dai, B., et al., Primary invasive carcinoma associated with penoscrotal extramammary P aget's disease: a clinicopathological analysis of 56 cases. BJU international, 2015. 115(1): p. 153-160.
25. Ito, T., et al., Tumor thickness as a prognostic factor in extramammary Paget's disease. The Journal of Dermatology, 2015. 42(3): p. 269-275.
26. Ito, T., Y. Kaku-Ito, and M. Furue, The diagnosis and management of extramammary Paget’s disease. Expert Rev Anticancer Ther, 2018. 18(6): p. 543-553.
27. Zhao, Y., et al., Primary extramammary Paget’s disease: a clinicopathological study of 28 cases. Int J Clin Exp Pathol, 2019. 12(9): p. 3426.
28. Belousova, I.E., et al., Vulvar toker cells: the long-awaited missing link: a proposal for an origin-based histogenetic classification of extramammary paget disease. The American journal of dermatopathology, 2006. 28(1): p. 84-86.
29. Goldblum, J.R. and W.R. Hart, Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases. The American journal of surgical pathology, 1997. 21(10): p. 1178-1187.
30. Hart, W.R. and J.B. Millman, Progression of intraepithelial Paget's disease of the vulva to invasive carcinoma. Cancer, 1977. 40(5): p. 2333-2337.
31. Konstantinova, A.M., et al., Depth and patterns of adnexal involvement in primary extramammary (anogenital) Paget disease: a study of 178 lesions from 146 patients. Am J Dermatopathol, 2016. 38(11): p. 802-808.
32. Karam, A., et al., HER-2/neu targeting for recurrent vulvar Paget's disease: a case report and literature review. Gynecologic oncology, 2008. 111(3): p. 568-571.
33. Takahagi, S., et al., Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. The Journal of dermatology, 2009. 36(8): p. 457-461.
34. Delport, E.S., Extramammary Paget's disease of the vulva: an annotated review of the current literature. Australasian Journal of Dermatology, 2013. 54(1): p. 9-21.
35. Wollina, U., et al., Surgical treatment for extramammary Paget’s disease. Current treatment options in oncology, 2018. 19: p. 1-12.
36. Long, B., et al., A matter of margins: Surgical and pathologic risk factors for recurrence in extramammary Paget's disease. Gynecologic oncology, 2017. 147(2): p. 358-363.
37. Nabavizadeh, R., et al., Extramammary Paget's disease: Updates in the workup and management. Asian Journal of Urology, 2022. 9(4): p. 451-459.
38. Oashi, K., et al., Combination chemotherapy for metastatic extramammary Paget disease. British Journal of Dermatology, 2014. 170(6): p. 1354-1357.
39. Tanese, K., et al., Updates on the systemic treatment of advanced non-melanoma skin cancer. Frontiers in medicine, 2019. 6: p. 160.
40. Tokuda, Y., F. Arakura, and H. Uhara, Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget’s disease. International journal of clinical oncology, 2015. 20: p. 194-197.